search
Back to results

Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women

Primary Purpose

Malnutrition

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Treatment 1: Control
Treatment 2: Bolus (LNS)
Treatment 3: Divided Dose (LNS)
Sponsored by
USDA, Western Human Nutrition Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Malnutrition

Eligibility Criteria

18 Years - 40 Years (Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • Mother 18-40 years of age
  • Apparently healthy, with no acute illness
  • Willing to stay in clinic for breast milk sampling, and adhere to all study procedures
  • 4-6 months of lactation and ≥ 8 breast feeding episodes per day (usual frequency is >20 times/day)
  • Last birth was a singleton birth
  • Only breastfeeding one child
  • Child is 4-6 months of age

Exclusion Criteria:

  • Current supplement use (iron + folic acid excepted)
  • Self reported mastitis or other breast infections
  • Reported problems with breastfeeding which might affect study procedures
  • Last birth was premature (>4 weeks pre-term by maternal report)
  • Measured body mass index (BMI) of less than 18.5 or a measured mid upper arm circumference (MUAC) of less than 12.5 cm
  • Temporary- if the mother or her infant present with an acute illness, (for example flu or diarrhea,) they will be rescheduled to return on a later date when both are apparently healthy.
  • Allergy to milk, milk products, or peanuts.

Sites / Locations

  • USDA, ARS, Western Human Nutrition Research Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm 4

Arm 5

Arm 6

Arm Type

Experimental

Experimental

Experimental

Experimental

Experimental

Experimental

Arm Label

Group 1

Group 2

Group 3

Group 4

Group 5

Group 6

Arm Description

Treatment 1: Control - no supplement given Treatment 2: Bolus - LNS supplement provided in one dose Treatment 3: Divided Dose - LNS supplement provided in 3 doses

Treatment 1: Control - no supplement given Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 2: Bolus - LNS supplement provided in one dose

Treatment 2: Bolus - LNS supplement provided in one dose Treatment 1: Control - no supplement given Treatment 3: Divided Dose - LNS supplement provided in 3 doses

Treatment 2: Bolus - LNS supplement provided in one dose Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 1: Control - no supplement given

Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 2: Bolus - LNS supplement provided in one dose Treatment 1: Control - no supplement given

Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 1: Control - no supplement given Treatment 2: Bolus - LNS supplement provided in one dose

Outcomes

Primary Outcome Measures

Change in Cobalamin (vitamin B12) in Breast Milk
We are observing the change in breast milk vitamin B12 over the course of 8 hours.
Change in Pyridoxal (vitamin B6) in Breast Milk
We are observing the change in breast milk vitamin B6 over the course of 8 hours.
Change in Riboflavin (vitamin B2) in Breast Milk
We are observing the change in breast milk vitamin B2 over the course of 8 hours.
Change in Niacin (vitamin B3) in Breast Milk
We are observing the change in breast milk vitamin B5 over the course of 8 hours.
Change in Thiamin (vitamin B1) in Breast Milk
We are observing the change in breast milk vitamin B1 over the course of 8 hours.

Secondary Outcome Measures

Maternal cobalamin (vitamin B12) status
Maternal cobalamin (vitamin B12) status will be measured in blood.
Maternal pyridoxal (vitamin B6) status
Maternal pyridoxal (vitamin B6) will be measured in blood.
Maternal riboflavin (vitamin B2) status
Maternal riboflavin (vitamin B2) will be measured in blood.
Maternal niacin (vitamin B3) status
Maternal niacin (vitamin B5) will be measured in blood.
Maternal thiamin (vitamin B1) status
Maternal thiamin (vitamin B1) will be measured in blood.
Change in Infant Milk Consumption
Infants will be test-weighed before and after each feed to calculate milk intake during the study visits. We are observing the change in breast milk intake over the course of 8 hours.

Full Information

First Posted
April 22, 2015
Last Updated
September 4, 2015
Sponsor
USDA, Western Human Nutrition Research Center
Collaborators
University of California, Davis, Blum Center for Developing Economies, Fogarty International Center of the National Institute of Health, Center for the Studies of Sensory Impairment, Aging and Metabolism (CeSSIAM)
search

1. Study Identification

Unique Protocol Identification Number
NCT02464111
Brief Title
Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women
Official Title
Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women
Study Type
Interventional

2. Study Status

Record Verification Date
September 2015
Overall Recruitment Status
Completed
Study Start Date
May 2015 (undefined)
Primary Completion Date
August 2015 (Actual)
Study Completion Date
August 2015 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
USDA, Western Human Nutrition Research Center
Collaborators
University of California, Davis, Blum Center for Developing Economies, Fogarty International Center of the National Institute of Health, Center for the Studies of Sensory Impairment, Aging and Metabolism (CeSSIAM)

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
Research goals include evaluating the relative impact of maternal nutritional status versus recent dietary intake on breast milk micronutrient composition, and evaluating the impact of a maternal lipid based nutrient supplement (LNS) on breast milk micronutrient composition.
Detailed Description
The study includes a cross sectional and an interventional component. Maternal dietary intake and nutritional status will be compared to breast milk micronutrient composition in a cross sectional manner. The short term effect of maternal dietary intake on breast milk micronutrient composition will be examined using an intervention with a controlled diet and LNS. Infants will be test-weighed during the LNS intervention in order to calculate the infant micronutrient intake from the control and LNS intervention days. Mother-infant dyads will be recruited into the study and the order in which they will receive the 3 treatments will be randomized. All mothers will receive all treatments. The mothers will be invited to the clinic on 4 separate occasions. During the first study visit, maternal blood will be collected, anthropometric indices will be assessed, and food frequency and demographic characteristic surveys will be administered. During the 2-4 visits, the LNS intervention will take place. Mothers will arrive at the clinic fasted, and a fasted milk collection will occur. Subsequently, mothers will be provided 3 meals based on local foods with low-nutrient density. Milk will be collected for 8 hours at each infant feed (ad libitum). A 24 hour dietary recall will be conducted. Mothers will receive 1) no LNS, 2) A single dose of LNS with breakfast, or 3) A single dose of LNS split into 3 parts with their meals throughout the day. Infants will be test weighed before and after each feed to calculate their nutrient intake from breast milk and the impact of the different supplementation schemes on their nutrient intake.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Malnutrition

7. Study Design

Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
30 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Group 1
Arm Type
Experimental
Arm Description
Treatment 1: Control - no supplement given Treatment 2: Bolus - LNS supplement provided in one dose Treatment 3: Divided Dose - LNS supplement provided in 3 doses
Arm Title
Group 2
Arm Type
Experimental
Arm Description
Treatment 1: Control - no supplement given Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 2: Bolus - LNS supplement provided in one dose
Arm Title
Group 3
Arm Type
Experimental
Arm Description
Treatment 2: Bolus - LNS supplement provided in one dose Treatment 1: Control - no supplement given Treatment 3: Divided Dose - LNS supplement provided in 3 doses
Arm Title
Group 4
Arm Type
Experimental
Arm Description
Treatment 2: Bolus - LNS supplement provided in one dose Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 1: Control - no supplement given
Arm Title
Group 5
Arm Type
Experimental
Arm Description
Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 2: Bolus - LNS supplement provided in one dose Treatment 1: Control - no supplement given
Arm Title
Group 6
Arm Type
Experimental
Arm Description
Treatment 3: Divided Dose - LNS supplement provided in 3 doses Treatment 1: Control - no supplement given Treatment 2: Bolus - LNS supplement provided in one dose
Intervention Type
Other
Intervention Name(s)
Treatment 1: Control
Intervention Description
No supplement provided.
Intervention Type
Dietary Supplement
Intervention Name(s)
Treatment 2: Bolus (LNS)
Intervention Description
One LNS supplement provided in a single bolus dose in the morning
Intervention Type
Dietary Supplement
Intervention Name(s)
Treatment 3: Divided Dose (LNS)
Intervention Description
One LNS supplement provided in 3 separate portions throughout the study visit
Primary Outcome Measure Information:
Title
Change in Cobalamin (vitamin B12) in Breast Milk
Description
We are observing the change in breast milk vitamin B12 over the course of 8 hours.
Time Frame
Breast milk cobalamin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits/weeks 2, 3, & 4 will each be held approximately 1 week apart.
Title
Change in Pyridoxal (vitamin B6) in Breast Milk
Description
We are observing the change in breast milk vitamin B6 over the course of 8 hours.
Time Frame
Breast milk pyridoxal will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits/weeks 2, 3, & 4 will each be held approximately 1 week apart.
Title
Change in Riboflavin (vitamin B2) in Breast Milk
Description
We are observing the change in breast milk vitamin B2 over the course of 8 hours.
Time Frame
Breast milk riboflavin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart.
Title
Change in Niacin (vitamin B3) in Breast Milk
Description
We are observing the change in breast milk vitamin B5 over the course of 8 hours.
Time Frame
Breast milk niacin will be assessed in an 8-hour milk sample on each of three study visit days (Visits 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart.
Title
Change in Thiamin (vitamin B1) in Breast Milk
Description
We are observing the change in breast milk vitamin B1 over the course of 8 hours.
Time Frame
Breast milk thiamin will be assessed in an 8-hour milk sample on each of three study visit days (Visits/weeks 2, 3, and 4.) Study visits 2, 3, & 4 will each be held approximately 1 week apart.
Secondary Outcome Measure Information:
Title
Maternal cobalamin (vitamin B12) status
Description
Maternal cobalamin (vitamin B12) status will be measured in blood.
Time Frame
Measured once prior to first study visit (week 1)
Title
Maternal pyridoxal (vitamin B6) status
Description
Maternal pyridoxal (vitamin B6) will be measured in blood.
Time Frame
Measured once prior to first study visit (week 1)
Title
Maternal riboflavin (vitamin B2) status
Description
Maternal riboflavin (vitamin B2) will be measured in blood.
Time Frame
Measured once prior to first study visit (week 1)
Title
Maternal niacin (vitamin B3) status
Description
Maternal niacin (vitamin B5) will be measured in blood.
Time Frame
Measured once prior to first study visit (week 1)
Title
Maternal thiamin (vitamin B1) status
Description
Maternal thiamin (vitamin B1) will be measured in blood.
Time Frame
Measured once prior to first study visit (week 1)
Title
Change in Infant Milk Consumption
Description
Infants will be test-weighed before and after each feed to calculate milk intake during the study visits. We are observing the change in breast milk intake over the course of 8 hours.
Time Frame
Breast milk consumption for an 8-hour period will be assessed on each of three study visit days (Visits/weeks 2, 3, and 4). Study visits 2, 3, & 4 will each be held approximately 1 week apart.

10. Eligibility

Sex
Female
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
40 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: Mother 18-40 years of age Apparently healthy, with no acute illness Willing to stay in clinic for breast milk sampling, and adhere to all study procedures 4-6 months of lactation and ≥ 8 breast feeding episodes per day (usual frequency is >20 times/day) Last birth was a singleton birth Only breastfeeding one child Child is 4-6 months of age Exclusion Criteria: Current supplement use (iron + folic acid excepted) Self reported mastitis or other breast infections Reported problems with breastfeeding which might affect study procedures Last birth was premature (>4 weeks pre-term by maternal report) Measured body mass index (BMI) of less than 18.5 or a measured mid upper arm circumference (MUAC) of less than 12.5 cm Temporary- if the mother or her infant present with an acute illness, (for example flu or diarrhea,) they will be rescheduled to return on a later date when both are apparently healthy. Allergy to milk, milk products, or peanuts.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Juliana A Haber, B.S.
Organizational Affiliation
USDA WHNRC, UC Davis
Official's Role
Principal Investigator
Facility Information:
Facility Name
USDA, ARS, Western Human Nutrition Research Center
City
Davis
State/Province
California
ZIP/Postal Code
95616
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
32649760
Citation
Donohue JA, Solomons NW, Hampel D, Shahab-Ferdows S, Orozco MN, Allen LH. Micronutrient supplementation of lactating Guatemalan women acutely increases infants' intake of riboflavin, thiamin, pyridoxal, and cobalamin, but not niacin, in a randomized crossover trial. Am J Clin Nutr. 2020 Sep 1;112(3):669-682. doi: 10.1093/ajcn/nqaa147.
Results Reference
derived

Learn more about this trial

Short Term Response of Breast Milk Micronutrient Concentrations to a Lipid Based Nutrient Supplement in Guatemalan Women

We'll reach out to this number within 24 hrs